Short-term mechanisms activated by NGF to induce pulmonary arterial hyperreactivity

C. BOUCHET (Pessac, France), G. Cardouat (Pessac, France), M. Douart (Pessac, France), P. Robillard (Pessac, France), R. Marthan (Pessac, France), B. Muller (Pessac, France), C. Guibert (Pessac, France), V. Freund-Michel (Pessac, France)

Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Session: Pathogenesis and pathophysiology of pulmonary hypertension
Session type: E-poster
Number: 585

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. BOUCHET (Pessac, France), G. Cardouat (Pessac, France), M. Douart (Pessac, France), P. Robillard (Pessac, France), R. Marthan (Pessac, France), B. Muller (Pessac, France), C. Guibert (Pessac, France), V. Freund-Michel (Pessac, France). Short-term mechanisms activated by NGF to induce pulmonary arterial hyperreactivity. 585

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
NGF induces pulmonary arterial hyperreactivity through connexin 43 increased expression
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020


Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018

Alkalosis induce eNOS activation in human pulmonary arterial endothelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001

Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010

NMDA receptor activation promotes vascular remodeling and pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018

Corticosteroids inhibit perivascular recruitment of IL-6 producing cells, maintain BMPR-II pulmonary expression and prevent pulmonary hypertension in monocrotalin-exposed rats
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007

Phosphodiesterase-type 3 inhibitor potentiates cAMP generation and antiproliferative effects of treprostinil in pulmonary arterial smooth muscle cells from patients with pulmonary hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010


PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006


The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018



Concomitant exposure to nicotine and endotoxin in vitro induces murine airway hyperreactivity possibly via nicotine-induced upregulation of toll-like receptors
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011


Dexamethasone induces anti-remodelling effects in rat pulmonary arterial smooth muscle cells
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012


Small airway obstruction in severe pulmonary arterial hypertension correlates with increased airway CD8+ T-cells and fractalkine expression
Source: Eur Respir J 2009; 34: 1494-1496
Year: 2009


Bronchial vascular remodeling is attenuated by anti-IL17 in asthmatic responses exacerbated by LPS
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

HDAC inhibitor quisinostat reduces pulmonary vascular remodeling in experimentally induced pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020


Peripheral airway dysfunction persist after endothelin receptor antagonist therapy in patients with idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009


Interleukin-2 inhalation therapy temporarily induces asthma-like functional changes and airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003

Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018


Maladaptive Pulmonary vascular responses to chronic intermittent and sustained hypoxia in a rat hypertension model
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018